| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |